Dr. Reddy's Laboratories Ltd. closed 11.70% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Dr. Reddy's Laboratories Ltd. closed 11.34% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

Linda Jónsdóttir, Alvotech's Chief Financial Officer ...

CM Revanth Reddy pays tributes to Y S Rajasekhar Reddy and former PM Chandrashekhar. New Delhi/Hyderabad, July 8 (UNI) Telangana Chief Minister A Revanth Reddy paid rich tributes ...

Dr Reddy’s Laboratories Ltd. reported its Q2 FY25 results, with a notable revenue increase of 16.5%, reaching Rs 8,016.2 crore, surpassing estimates.

Dr Reddy's Q2 performance sees revenue boost, but challenges persist Dr Reddy’s Laboratories posted a mixed performance in Q2FY25, reporting record revenue of Rs 8,038.2 crore, marking a strong 16.5 ...

RDY’s Q2 Results in Detail Dr. Reddy’s reports revenues under three segments — Global Generics, Pharmaceutical Services & Active Ingredients (PSAI) and Others. Global Generics revenues totaled INR ...

Dr. Reddy's Laboratories Q2 net profit declines 9.5% to ₹1,341.9 crore, revenue surpasses ₹8,000 crore mark.

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2025 Earnings Conference Call November 5, 2024 9:00 AM ETCompany ParticipantsRicha Periwal - Head of Investor ...

Reddy’ s Laboratories Ltd. today announced its consolidated financial results for the quarter and half year ended September 30, 2024. The information mentioned in this release is based on ...

Indian generic drugmaker Dr Reddy's Laboratories' second-quarter profit was hit by one-time charges related to its joint venture with Nestle India and Nicotinell acquisition, the company said on ...